“Losartan, an Ang II receptor 1 blocker, and carvedilol, an alpha1-nonselective-beta1,2,3-adrenergic blocker, but not doxazosin, an alpha1-selective-adrenergic blocker , lowered glycerol and norepinephrine levels, preventing lipolysis and weight loss.”